Navigation Links
BioMS Medical announces its intention to renew a normal course issuer bid
Date:9/3/2008

cialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide (MBP8298), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide (MBP8298), in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...DAVIS, Calif., Nov. 18 Marrone Bio...elopment and commercialization of effective and en..., announced that it has been named an IC20 company...st and largest national angel investing group. ,...e leading to rewarding results for all stakeholder...
(Date:11/18/2009)...ts at Queen,s University Belfast are developing ne...ugs which will help in the fight against the threa...pecial gel pads to ,swipe, an individual or crime ... a scanning instrument that can detect the presenc...ter, faster decisions to be made in response to te...
(Date:11/18/2009)... EAST GRINSTEAD, West Sussex, U.K. and CLEVELAND, ... Magellan Biosciences business and premier provide...s for microbiology labs, has expanded its East Gri...opment facility to meet increasing global demand f...ility and identification testing. The expanded fac...
(Date:11/18/2009)..., BONITA SPRINGS, Fla., Nov. 18 A...ol® technology, and the technology group Th...t development project in order to identify the opt... (O2) for Algenol,s unique algae and photobioreact...nies join forces to develop cost-efficient technol...
Breaking Biology Technology:Marrone Bio Innovations Named an IC20 Company 2New technology detects chemical weapons in seconds 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
...samples in 1-day shift, INDIANAPOLIS, Sept. 14 R...time PCR test for HIV provides shorter turnaround,...competitors, according to,a new study published in...y. The study, conducted by Medical Laboratory Bre...th the COBAS(R) Ampliprep/COBAS(R) TaqMan(R),(CAP/...
...ationally, SCOTTSDALE, Ariz., Sept. 14 CHS, an i...tly honored by the U.S. Department,of Defense as a...er Support,Freedom Award. The award, sponsored by ...National Guard and Reserve (ESGR), is the highest ...e support to their employees,serving in the Nation...
...eriod-, SOUTH SAN FRANCISCO, Calif., Sept. 14 ,Ex... the company has,submitted a comprehensive data re...s announced in August 2007, GSK requested to initi...s proof-of-concept as defined under the,product de...the two,companies. GSK now has 90 days to review t...
Other Biology Technology:Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitor's 2CHS Receives Prestigious Honor from Department of Defense 2CHS Receives Prestigious Honor from Department of Defense 3Exelixis Submits XL880 Diligence Report to GlaxoSmithKline 2
(Date:11/19/2009)... of researchers at Louisiana Tech University has f... as a natural herbicide against giant salvinia. ,... weed that can block all sunlight penetration into...er ideal conditions, it,s been reported that giant... Dr. H. Lynn Walker, professor of biological scien...
(Date:11/19/2009)...study of maize has identified thousands of diverse... genome. New techniques may allow breeders and res... desirable traits and create new varieties that we...he Nov. 19 issue of Science , the researchers, wh...dentified the first map of haplotypes sets of clo...
(Date:11/19/2009)...w statistical technique developed by researchers a...scan a genome for specific gene-regulatory regions... transcription factors. The technique has been exp... the fruit fly genome. , "Our statistical approac... and is especially useful for investigating gene r...
Breaking Biology News(10 mins):Microorganism may provide key to combating giant salvinia throughout Louisiana 2New map of variation in maize genetics holds promise for developing new varieties 2Technique finds gene regulatory sites without knowledge of regulators 2Shaw to receive prestigious honor for plant pathology research 9171 1Genetic Breakthrough Spells Hope for Lung Fibrosis Patients 51092 1Genetic Breakthrough Spells Hope for Lung Fibrosis Patients 51092 2Communicating science to decision makers 51089 1
...t of Homeland,Security (DHS) announced today that ...om international visitors arriving at San Francisc...e is part of the,department,s upgrade from two- to... facilitate legitimate travel by more accurately a..., identities., "Biometrics have revolutionized ou...
...hers at the Georgia Institute of Technology have d...ly recycle carbon from vehicles to prevent the pol...to the atmosphere. Georgia Tech researchers envisi...m completely free of fossil fuels. , Technologies...ale sources such as power plants have recently gai...
...making a stop at the Smithsonians National Zoo. Un...quate with love and romance, mating and dating at ...-basedquite an unromantic encounter. , Successful...ing a male and female together and expecting natur... be managed carefully to ensure the most genetical...
Other Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport 2Carbon capture strategy could lead to emission-free cars 2Carbon capture strategy could lead to emission-free cars 3Carbon capture strategy could lead to emission-free cars 4Science, not romance, controls mating at Smithsonian's National Zoo 2Science, not romance, controls mating at Smithsonian's National Zoo 3
Canine serum from Equitech-Bio
Rabbit Anti-TOLLIP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...er Supply, 1. 1000 V, 400 mA, 100 W maximum.Consta...odes.Single-unit increments in settings and read-o...ecalls three protocols.Outstanding choice for non-...ePhor systems. Category: Electrophoresis Systems &...
Goat Anti-Mouse Nodal Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: